dihexa clinical trials humans human dihexa human clinical trials 2026 Clinical Trials Day 2026: Why Is It Important to Celebrate It? Dihexa in Clinical Trials: What

doi: 10.3390/life13091845

WHERE IT TREATS Muscles, tendons, ligaments, joints, and the gastrointestinal tract

It's essential to inform your provider about all medications you're taking

Examples include broccoli, cauliflower, and Brussel sprouts

You have three administration options: Option A: Injectable GHK-Cu only 200 to 600 mcg per day, subcutaneous Best for systemic tissue support (skin, joints, hair, internal tissues) No fasting required Option B: Topical GHK-Cu only Applied to target areas once or twice daily Best for localized skin concerns (face, abdomen, specific areas of laxity) Lower cost, no injection required Option C: Injectable plus topical (recommended for maximum benefit) Injectable for systemic support plus topical for targeted skin areas Most thorough approach Addresses both internal tissue health and external skin quality Step 4: Improve and Maintain As semaglutide is titrated up over the following months, continue GHK-Cu consistently